SEC Form 4 · accession 0001232524-18-000027
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Iain McGill
Officer — SVP, Europe & Rest of World
Period of report
Feb 26, 2018
Accepted (ET)
Feb 28, 2018 · 5:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Feb 26, 2018 | F | 937 | $147.44 | D | 19,446 | D | |
| Ordinary Shares | Feb 27, 2018 | F | 784 | $143.80 | D | 18,662 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.